Overview

Prozac Treatment of Major Depression: Discontinuation Study

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This study randomized two stratifications of acute phase MDD SSRI responders, categorized as having either "true drug" response or "placebo response" pattern, to continuation with SSRI vs placebo in a double-blind trial to determine if stratification category predicted continuation outcome.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
Massachusetts General Hospital
Treatments:
Fluoxetine